Get the Stockscreener App
0.5558
25.46%
0.1128
Pre-market:
.59
0.0342
+6.15%
Harvard Bioscience Inc Stock (HBIO) Forecast
The Harvard Bioscience Inc (HBIO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.7998, representing a +763.59% increase from the current price of $0.5558. The highest analyst price target is $5.3439, and the lowest is $4.2558.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HBIO Price Target
Average 6.8784
(+1,138% Upside)
Is Harvard Bioscience Inc (HBIO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.74 | Neutral |
| STOCH(9,6) | 59.29 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.00258 | Buy |
| ADX(14) | 28.04 | Buy |
| William %R | -12.38 | Sell |
| CCI(14) | 218.97 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4492
Buy
|
0.4641
Buy
|
| MA20 |
0.4568
Buy
|
0.4606
Buy
|
| MA50 |
0.4449
Buy
|
0.477
Buy
|
| MA100 |
0.4847
Buy
|
0.6661
Sell
|
| MA200 |
1.2592
Sell
|
1.229
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, HBIO could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on HBIO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63.74 indicates that HBIO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 59.29 indicates that HBIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that HBIO is oversold. This suggests that HBIO price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.04 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 218.97 indicates that HBIO is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term HBIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Harvard Bioscience Inc financial reports and earnings history, Harvard Bioscience Inc (HBIO) stock could reach $5.3154 by 2030, $11.90 by 2040 and $15.65 by 2050. See the projected annual prices until 2050 of the Harvard Bioscience Inc stock below:
- Harvard Bioscience Inc (HBIO) is expected to reach an average price of $8.8788 in 2035, with a high prediction of $8.9288 and a low estimate of $8.0079. This indicates an $1,497% rise from the last recorded price of $0.5558.
- Harvard Bioscience Inc (HBIO) stock is projected to chart a bullish course in 2040, with an average price target of $11.77, representing an $2,018% surge from its current level. The forecast ranges from a conservative $9.8379 to a sky-high $11.90.
- Our analysts predict Harvard Bioscience Inc (HBIO) to jump 1,728% by 2045, soaring from $9.9719 to an average price of $10.16, potentially reaching $10.92. While $9.9719 is the low estimate, the potential upside is significant.
- Harvard Bioscience Inc (HBIO) stock is expected to climb by 2050, reaching an average of $15.34, a $2,661% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.65 and $14.42, respectively, highlighting the market's uncertainty.
Harvard Bioscience Inc Stock (HBIO) Year by Year Forecast
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2025
Harvard Bioscience Inc Stock (HBIO) is expected to reach an average price of $4.4525 in 2025, with a high prediction of $5.9924 and a low estimate of $2.9125. This indicates an +701.09% rise from the last recorded price of $0.5558.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2025 | $5.0539 | $4.2558 | $5.3439 | +809.30% |
| September, 2025 | $5.7747 | $4.5185 | $5.8347 | +938.99% |
| October, 2025 | $4.7882 | $4.7282 | $5.9924 | +761.50% |
| November, 2025 | $4.6191 | $4.3464 | $4.9009 | +731.06% |
| December, 2025 | $5.0026 | $4.5418 | $5.1172 | +800.07% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2026
The predicted value for Harvard Bioscience Inc (HBIO) in 2026 is set at an average of $7.7384. Estimates vary from a peak of $10.49 to a trough of $4.9853, indicating an +1,292% surge from the present price of $0.5558.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.5034 | $4.9853 | $6.0307 | +890.18% |
| February, 2026 | $6.1092 | $5.3761 | $6.2242 | +999.18% |
| March, 2026 | $5.995 | $5.6969 | $6.305 | +978.63% |
| April, 2026 | $6.2686 | $5.7577 | $6.8759 | +1,028% |
| May, 2026 | $7.7794 | $5.544 | $8.7794 | +1,300% |
| June, 2026 | $8.2202 | $6.9148 | $8.3302 | +1,379% |
| July, 2026 | $8.7137 | $8.0929 | $9.501 | +1,468% |
| August, 2026 | $9.3545 | $8.4991 | $9.5645 | +1,583% |
| September, 2026 | $9.8981 | $8.7872 | $10.27 | +1,681% |
| October, 2026 | $9.6989 | $8.9435 | $10.19 | +1,645% |
| November, 2026 | $10.01 | $9.4566 | $10.49 | +1,701% |
| December, 2026 | $8.7532 | $8.6932 | $10.23 | +1,475% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Harvard Bioscience Inc (HBIO) is $7.5695, with a high forecast of $10.01 and a low forecast of $5.1295. This indicates an +1,262% increase from the last price of $0.5558.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.724 | $8.1313 | $9.0759 | +1,470% |
| February, 2027 | $9.2248 | $8.6867 | $10.01 | +1,560% |
| March, 2027 | $8.6384 | $8.1531 | $9.2576 | +1,454% |
| April, 2027 | $7.8692 | $7.7192 | $9.1638 | +1,316% |
| May, 2027 | $7.74 | $7.2919 | $7.97 | +1,293% |
| June, 2027 | $7.2535 | $6.8281 | $8.0077 | +1,205% |
| July, 2027 | $8.0543 | $7.1962 | $8.3062 | +1,349% |
| August, 2027 | $7.6752 | $7.5552 | $8.3398 | +1,281% |
| September, 2027 | $5.6187 | $5.2234 | $7.7579 | +910.92% |
| October, 2027 | $5.1595 | $5.1295 | $6.3618 | +828.30% |
| November, 2027 | $5.7903 | $5.2622 | $5.8722 | +941.80% |
| December, 2027 | $5.1838 | $5.1338 | $5.863 | +832.68% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2028
In 2028, Harvard Bioscience Inc (HBIO) is projected to reach an average price of $6.1267, with a high projection of $8.3101 and a low estimate of $3.9433. This indicates an +1,002% rise from the last price of $0.5558.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.1347 | $5.0065 | $5.3893 | +823.83% |
| February, 2028 | $4.4855 | $4.1955 | $5.2174 | +707.03% |
| March, 2028 | $4.629 | $4.0809 | $4.7482 | +732.85% |
| April, 2028 | $4.3598 | $4.0444 | $4.7117 | +684.42% |
| May, 2028 | $4.6933 | $3.9433 | $4.9267 | +744.43% |
| June, 2028 | $4.8642 | $4.366 | $4.9742 | +775.16% |
| July, 2028 | $5.185 | $4.7769 | $5.285 | +832.89% |
| August, 2028 | $4.6685 | $4.4185 | $5.2077 | +739.96% |
| September, 2028 | $6.2693 | $4.4312 | $6.3993 | +1,028% |
| October, 2028 | $8.1801 | $6.20 | $8.3101 | +1,372% |
| November, 2028 | $7.7637 | $7.1155 | $8.2328 | +1,297% |
| December, 2028 | $7.5345 | $7.2591 | $8.2418 | +1,256% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2029
The 2029 price forecast for Harvard Bioscience Inc Stock (HBIO) is $6.5699 on average, with a high prediction of $7.9299 and a low estimate of $5.21. This represents an +1,082% increase from the previous price of $0.5558.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.708 | $6.678 | $7.9299 | +1,107% |
| February, 2029 | $6.3788 | $6.0361 | $7.0107 | +1,048% |
| March, 2029 | $6.6296 | $6.1116 | $6.6996 | +1,093% |
| April, 2029 | $6.2304 | $6.095 | $6.7004 | +1,021% |
| May, 2029 | $6.104 | $5.904 | $6.6213 | +998.23% |
| June, 2029 | $6.5148 | $6.0167 | $6.8194 | +1,072% |
| July, 2029 | $7.4756 | $6.4175 | $7.6856 | +1,245% |
| August, 2029 | $6.5391 | $6.2837 | $7.5633 | +1,077% |
| September, 2029 | $6.5599 | $6.3499 | $7.0772 | +1,080% |
| October, 2029 | $6.3335 | $6.0035 | $6.7631 | +1,040% |
| November, 2029 | $5.8743 | $5.8643 | $6.8689 | +956.91% |
| December, 2029 | $5.21 | $5.21 | $6.1789 | +837.39% |
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2030
Harvard Bioscience Inc Stock (HBIO) is expected to reach an average price of $5.4137 in 2030, with a high forecast of $6.4788 and a low forecast of $4.3487. This signifies an +874.05% surge from the last price of $0.5558.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.847 | $4.722 | $5.3154 | +772.08% |
| February, 2030 | $4.7187 | $4.3487 | $4.9725 | +748.99% |
| March, 2030 | $5.2203 | $4.5641 | $5.5195 | +839.24% |
| April, 2030 | $5.352 | $5.0857 | $5.6765 | +862.93% |
| May, 2030 | $5.979 | $5.1874 | $6.3382 | +975.75% |
| June, 2030 | $5.6706 | $5.5152 | $6.1044 | +920.26% |
| July, 2030 | $5.9677 | $5.3369 | $6.3327 | +973.71% |
| August, 2030 | $5.8193 | $5.7193 | $6.0885 | +947.02% |
| September, 2030 | $6.0909 | $5.7847 | $6.2109 | +995.89% |
| October, 2030 | $5.618 | $5.608 | $6.27 | +910.79% |
| November, 2030 | $5.2696 | $5.0896 | $6.4788 | +848.12% |
| December, 2030 | $5.1813 | $4.435 | $5.4704 | +832.22% |
2.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):